ArticleFrontiers in physiology2026
Brain-dead humans as preclinical reference models for xenotransfusion: bridging nonhuman primates and clinical applications through
Article in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Cell and tissue xenotransplantation: clinical purpose determines translational strategy and therapeutic endpoints.Clinical transplantation and research · 2026Review
- Rethinking preclinical models for genetically engineered porcine red blood cell xenotransfusion.Cell transplantationArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Xenotransfusion using genetically engineered (GE) pig red blood cells (RBCs) offers a promising solution to blood shortages, particularly in emergency settings. Although nonhuman primates (NHPs) have been widely used in preclinical studies, their translational relevance is limited by species-specific immune responses and logistical challenges. This study aimed to evaluate whether brain-dead humans could serve as a human translational reference model by characterizing and comparing their hematologic, biochemical, and immunologic profiles with those of patients with acute blood loss (ABL). The goal was to generate baseline data to inform the design and interpretation of future Materials and methods: Comprehensive clinical and immunological analyses were performed on donation after brain death (DBD) subjects (n=179) and patients with ABL requiring transfusion (n=104). The parameters included hematological indices, electrolytes, coagulation factors, inflammatory biomarkers, and arterial blood gases. Immune assays were conducted on sera from DBD subjects (n=31) and patients with ABL (n=102) to examine IgM/IgG binding and complement-dependent cytotoxicity (CDC) against triple-knockout (TKO) pig RBCs lacking Gal, Neu5Gc, and Sda antigens. Results: Across most measured parameters, overlapping ranges in hematologic and biochemical indices were observed between DBD subjects and patients with ABL. Anti-TKO IgM/IgG binding and CDC were not detectably different between the two groups under the conditions tested. However, differences were observed in several other immune parameters, including hemagglutination, cytokine profiles, total immunoglobulin levels, and complement components. Conclusion: Brain-dead humans may represent an ethically feasible human translational reference model for xenotransfusion research. While DBD subjects do not fully reproduce the physiologic and inflammatory milieu of patients with ABL, they provide useful baseline human data for assessing selected early xenoreactive responses to GE pig RBCs and may help bridge the translational gap between NHP studies and future clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.